Cancel GSP certification: Can SF replace medical e-commerce?
After the state canceled the approval of the third-party logistics business of drugs, the news of the GMP and GSP certification will be cancelled when the drug management law is further revised. It is interpreted by some media that the third-party logistics such as SF will completely replace the pharmaceutical business. Is it accurate? Why is the pharmaceutical industry misunderstood? Drugs are a highly specialized field. From research and development, production to sales and operation, they are implemented by professional personnel and institutions. They have strict approval and approval procedures and strict software and hardware management and facility compliance requirements. The national three-five application strengthens the quality and safety of drug production and operation. After the implementation of the new GSP, the pharmaceutical business has greatly improved from the requirements of software and hardware. Each business has also paid a lot of renovation costs and invested a lot of energy to upgrade the standard. After the outbreak of the vaccine case, the pharmaceutical business individual was strictly controlled with unprecedented intensity. At this point, the flood discharge gate of the pharmaceutical distribution, which is the last mile of product quality and safety, was suddenly released. More media misinterpretation, It is still not clear about the role and positioning of the production, management, distribution and logistics enterprises in the pharmaceutical sales. It lacks the overall concept and understanding of modern pharmaceutical marketing and management, and then the production enterprises are simple in various policy revisions. Positioned as a flour mill, only supply, no need to do any sales and promotion; the medical institution is positioned as a leisure restaurant, unified purchase and marketing, random price and charge; the pharmaceutical business is mistaken as the bearer of product sales, will actually undertake the sales function Acting customers to clear out; nowadays, the freight company replaces the role of traditional medicine business, all kinds of roles are wrongly inverted, is it scientific and professional? As everyone knows, we are accustomed to the daily necessities and food sales in the supermarket, but also have a scientific marketing system, but also have a variety of promotional inputs and effective marketing management and brand promotion, otherwise the payment of fees into the goods, no one knows, no one Purchases will still be cleared as they are. This is especially true for networks, where online advertising costs are much higher than physical marketing. Drugs are special products for treating diseases and saving people. Hospitals have higher sales thresholds and more intense competition. Each product has its own unique attributes. The company must provide professional training and services to help the health care workers in the busy schedule to better understand the most cutting-edge treatment programs and subject progress in related fields at home and abroad. Products and treatments are available to clinical patients to accurately and efficiently master product characteristics and precautions for use, and to address all types of problems in clinical applications. Medical control fees, playing tiger OR to fight sheep? The company's product research and development investment starts from tens of millions. The plant and facilities that meet the new GMP requirements will be tens of millions and billions. The marketing cost of single products will be several million and tens of millions per year. The requirements for the pharmaceutical industry are relatively high. Specialized education and training are required, and professional personnel with relevant experience are responsible for it. It is also necessary to pay at least millions and tens of millions of salary for the expenses of the company. Only good products, no good marketing and modern management, the fate of the company is only closed down. If the policy adjustments do not take into account the various inputs and expenses of the enterprise, and even believe that the company does not have the necessary and demand for marketing, contrary to the market rules and modern management concepts, it will cause accidental injury and injury to the pharmaceutical industry and enterprises. On the other hand, the tiger is still enjoying the medical expenses. Lack of comprehensive improvement and rectification of the scientific system, lack of perfect system construction, medical expenses incurred by medical institutions, and solely to blame the pharmaceutical companies, the tigers will be forced to take advantage of the sheep, and the effectiveness of the drug reform will be? The lower the price of medicines, the lower the price of medicines in various enterprises, but why is the medical expenses not decreasing simultaneously, but the faster and faster? The state canceled the 15% medical bonus, but the hospital and the pharmaceutical company had to go 20%, 30%, or even 50% of the second bargaining profit, still sold to the patient at the original price, and the medical expenses were greatly adjusted. Is this policy Reasonable and legal, is it a bigger medicine to raise medicine, which leads to a faster rise in medical expenses, and the burden of medical treatment for the people is heavier? It is the excessive bidding and bidding that has caused the medium and low-priced products that have already faced difficulties to be worsened. The lack of professional sales teams in the bid-winning enterprises is unable to operate. Such products are not enough to support the investment team, let alone self-built self-employed teams. The customer does not look up, the doctor does not care. As for entering the catalogue, it is hopeless to enter the medical insurance. On the contrary, it has accelerated the rapid rise of low- and mid-priced products in the market and the replacement of high-priced products. There are more restrictions on drug use in enterprises, but the mechanism of medical institutions has not been rationalized from the roots. It also exacerbates the cost of inspections, the rapid rise of major surgery and consumables, and the blowout. The latter is easier and higher, and doctors are used to such a tall Afterwards, the selection of drugs was more selective, which made the survival of ordinary drugs more difficult. Drug companies and patients became victims together. Pharmaceutical powder raw material
Pharmaceutical powder raw material,Lenalidomide Dexamethasone, Lamivudine Intermediate for Sale,Lubiprostone for Constipation,
Xi'an Henrikang Biotech Co., Ltd., was established in May 2010, and located in Gaoling Industrial Park, Xi`an city, Shaanxi Province, China. It is a professional supplier of Healthcare Products, Vitamin And Enzyme, Human APIs , Cosmetic Raw , Veterinary Products, Food Additives , Plant Extract and natural active ingredients. It has absolute advantage because of strong research strength, modern management system and high-quality marketing team. Pharmaceutical powder raw material,Lenalidomide Dexamethasone, Lamivudine Intermediate for Sale,Lubiprostone for Constipation Xi'an Henrikang Biotech Co.,Ltd , https://www.xianhenrikangbio.com
Now we have 3 GMP standard workshop, Meanwhile, the factory is equipped with the researching and quality inspection centre, with strong technology research and development strength. We also have 3 salesdepartments over 30 people and sell our products all over the world. For customer`s needs, OEM service is also acceptable. If you have a good idea in new product production but lack of laboratory device and human resource, we are glad to solve this problem for you. Sincerely hope to strengthen exchanges and cooperation with friends from both home and abroad.